| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Candida albicans | 11 | 2012 | 186 | 1.590 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 3 | 2024 | 520 | 1.440 |
Why?
|
| Gene Regulatory Networks | 15 | 2024 | 680 | 1.380 |
Why?
|
| Pheromones | 7 | 2011 | 27 | 1.290 |
Why?
|
| Neoplasms | 19 | 2023 | 15933 | 1.030 |
Why?
|
| Genes, Mating Type, Fungal | 9 | 2012 | 11 | 0.940 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2024 | 59 | 0.940 |
Why?
|
| Protein Interaction Maps | 7 | 2024 | 151 | 0.890 |
Why?
|
| Gene Expression Regulation, Fungal | 8 | 2012 | 107 | 0.860 |
Why?
|
| Genomics | 8 | 2022 | 2837 | 0.850 |
Why?
|
| Organelles | 1 | 2022 | 43 | 0.820 |
Why?
|
| BRCA1 Protein | 2 | 2023 | 528 | 0.800 |
Why?
|
| Phenotype | 16 | 2024 | 6517 | 0.740 |
Why?
|
| Fungal Proteins | 9 | 2011 | 271 | 0.720 |
Why?
|
| Evolution, Molecular | 3 | 2016 | 867 | 0.680 |
Why?
|
| Mutation | 21 | 2023 | 15915 | 0.670 |
Why?
|
| Biofilms | 7 | 2012 | 205 | 0.670 |
Why?
|
| Signal Transduction | 16 | 2024 | 12108 | 0.600 |
Why?
|
| Antigens | 1 | 2018 | 281 | 0.580 |
Why?
|
| RNA-Binding Proteins | 2 | 2023 | 1017 | 0.570 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2021 | 2359 | 0.550 |
Why?
|
| Genotype | 5 | 2021 | 4255 | 0.520 |
Why?
|
| Precision Medicine | 4 | 2023 | 1208 | 0.500 |
Why?
|
| RNA | 2 | 2024 | 1064 | 0.490 |
Why?
|
| Gene Dosage | 1 | 2018 | 823 | 0.490 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 271 | 0.480 |
Why?
|
| Genome | 2 | 2022 | 690 | 0.450 |
Why?
|
| Reproduction, Asexual | 2 | 2012 | 5 | 0.450 |
Why?
|
| Genetic Variation | 4 | 2021 | 2166 | 0.450 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 4134 | 0.430 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 1099 | 0.420 |
Why?
|
| Proteome | 4 | 2020 | 571 | 0.420 |
Why?
|
| Alternative Splicing | 4 | 2023 | 611 | 0.420 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1032 | 0.420 |
Why?
|
| Liver Neoplasms | 3 | 2019 | 4821 | 0.400 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 2573 | 0.360 |
Why?
|
| Models, Genetic | 2 | 2015 | 1164 | 0.350 |
Why?
|
| alpha-Synuclein | 2 | 2024 | 118 | 0.350 |
Why?
|
| DNA Damage | 5 | 2024 | 1991 | 0.340 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2017 | 175 | 0.330 |
Why?
|
| Computational Biology | 3 | 2021 | 1293 | 0.330 |
Why?
|
| Humans | 54 | 2024 | 271010 | 0.300 |
Why?
|
| Transcriptome | 5 | 2020 | 1962 | 0.300 |
Why?
|
| Mutation, Missense | 4 | 2024 | 1193 | 0.290 |
Why?
|
| Transcription Factors | 7 | 2020 | 5442 | 0.290 |
Why?
|
| DNA-Binding Proteins | 5 | 2020 | 5002 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2023 | 9045 | 0.270 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2175 | 0.260 |
Why?
|
| RNA, Long Noncoding | 2 | 2023 | 618 | 0.250 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 2351 | 0.250 |
Why?
|
| Inclusion Bodies | 1 | 2024 | 87 | 0.230 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 3341 | 0.230 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2017 | 341 | 0.220 |
Why?
|
| Disease | 2 | 2015 | 165 | 0.220 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2024 | 322 | 0.210 |
Why?
|
| Pyroptosis | 1 | 2023 | 39 | 0.210 |
Why?
|
| Protein Interaction Mapping | 4 | 2016 | 168 | 0.210 |
Why?
|
| Homologous Recombination | 1 | 2023 | 187 | 0.210 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2016 | 662 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 223 | 0.200 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2016 | 459 | 0.200 |
Why?
|
| RNA Isoforms | 1 | 2021 | 8 | 0.200 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2023 | 220 | 0.200 |
Why?
|
| Animals | 16 | 2024 | 62063 | 0.200 |
Why?
|
| Stress, Physiological | 2 | 2023 | 493 | 0.190 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 380 | 0.190 |
Why?
|
| Drug Resistance, Fungal | 2 | 2012 | 98 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 362 | 0.190 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 5151 | 0.180 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 14853 | 0.180 |
Why?
|
| Arginine | 1 | 2023 | 508 | 0.180 |
Why?
|
| MicroRNAs | 3 | 2023 | 2887 | 0.180 |
Why?
|
| Research | 1 | 2022 | 427 | 0.170 |
Why?
|
| Cyclopentanes | 1 | 2020 | 43 | 0.170 |
Why?
|
| DNA Replication | 1 | 2023 | 771 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 172 | 0.170 |
Why?
|
| HEK293 Cells | 3 | 2020 | 1462 | 0.170 |
Why?
|
| Protein Folding | 2 | 2017 | 297 | 0.160 |
Why?
|
| Protein Isoforms | 2 | 2023 | 848 | 0.160 |
Why?
|
| Extracellular Space | 1 | 2018 | 148 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 327 | 0.150 |
Why?
|
| Cell Line | 2 | 2023 | 5339 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 3920 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 5779 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2023 | 797 | 0.150 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 1431 | 0.150 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 126 | 0.150 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 283 | 0.150 |
Why?
|
| Databases, Genetic | 2 | 2018 | 757 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 876 | 0.150 |
Why?
|
| Algorithms | 4 | 2024 | 3900 | 0.150 |
Why?
|
| Ascorbate Peroxidases | 1 | 2017 | 2 | 0.140 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 304 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 661 | 0.140 |
Why?
|
| Systems Integration | 1 | 2016 | 68 | 0.140 |
Why?
|
| Phosphorylation | 4 | 2020 | 4945 | 0.140 |
Why?
|
| Fanconi Anemia | 1 | 2017 | 90 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 631 | 0.130 |
Why?
|
| Genetic Complementation Test | 1 | 2016 | 146 | 0.130 |
Why?
|
| Centrosome | 1 | 2016 | 106 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2018 | 437 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2023 | 1718 | 0.130 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2017 | 191 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 819 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 768 | 0.130 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3346 | 0.130 |
Why?
|
| Protein Stability | 3 | 2024 | 377 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 714 | 0.120 |
Why?
|
| Exome | 2 | 2017 | 1248 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2023 | 7239 | 0.120 |
Why?
|
| Mice | 6 | 2024 | 35608 | 0.120 |
Why?
|
| Fluconazole | 2 | 2012 | 107 | 0.120 |
Why?
|
| Lamin Type A | 1 | 2014 | 13 | 0.120 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 1442 | 0.110 |
Why?
|
| Proteomics | 2 | 2018 | 1427 | 0.110 |
Why?
|
| Gene Editing | 1 | 2016 | 229 | 0.110 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 117 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1195 | 0.110 |
Why?
|
| Chromatin | 1 | 2018 | 1046 | 0.110 |
Why?
|
| Receptors, Mating Factor | 2 | 2011 | 4 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1020 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2023 | 1776 | 0.100 |
Why?
|
| Color | 2 | 2008 | 73 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 123 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2020 | 4569 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 1838 | 0.100 |
Why?
|
| Base Sequence | 3 | 2016 | 5437 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2021 | 6398 | 0.090 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2011 | 35 | 0.090 |
Why?
|
| Carbon Dioxide | 2 | 2010 | 328 | 0.090 |
Why?
|
| Protein Binding | 5 | 2016 | 3485 | 0.090 |
Why?
|
| Immunotherapy | 3 | 2020 | 3557 | 0.090 |
Why?
|
| Neurons | 2 | 2024 | 2454 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 1387 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 2116 | 0.090 |
Why?
|
| Cell Movement | 1 | 2018 | 2474 | 0.090 |
Why?
|
| Acetylglucosamine | 1 | 2010 | 26 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2022 | 2423 | 0.090 |
Why?
|
| Biological Evolution | 1 | 2011 | 290 | 0.080 |
Why?
|
| Genome, Human | 4 | 2020 | 1888 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 885 | 0.080 |
Why?
|
| Cytokines | 1 | 2018 | 2826 | 0.080 |
Why?
|
| Protein Transport | 2 | 2024 | 737 | 0.080 |
Why?
|
| Blotting, Northern | 1 | 2009 | 726 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 4795 | 0.080 |
Why?
|
| Candida glabrata | 1 | 2008 | 48 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 669 | 0.080 |
Why?
|
| Receptors, Pheromone | 1 | 2007 | 1 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2018 | 2767 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2400 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 10709 | 0.080 |
Why?
|
| Culture Media | 1 | 2008 | 343 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 2388 | 0.070 |
Why?
|
| DNA | 1 | 2016 | 3051 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2020 | 3671 | 0.070 |
Why?
|
| Carcinogenesis | 2 | 2023 | 1033 | 0.070 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2020 | 295 | 0.070 |
Why?
|
| Proteins | 1 | 2015 | 2043 | 0.070 |
Why?
|
| Asthma | 1 | 2015 | 895 | 0.070 |
Why?
|
| Neutrophils | 1 | 2011 | 873 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 4962 | 0.070 |
Why?
|
| DNA Repair | 1 | 2014 | 1910 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2007 | 342 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 4958 | 0.070 |
Why?
|
| Candidiasis | 1 | 2008 | 278 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2023 | 1685 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 3109 | 0.070 |
Why?
|
| Phylogeny | 1 | 2008 | 867 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2008 | 1028 | 0.070 |
Why?
|
| Gene Expression | 2 | 2015 | 3643 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 6686 | 0.060 |
Why?
|
| Survival Rate | 1 | 2019 | 12542 | 0.060 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2024 | 23 | 0.060 |
Why?
|
| Open Reading Frames | 2 | 2016 | 276 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2023 | 2453 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5409 | 0.060 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2023 | 44 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2009 | 3588 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 4895 | 0.050 |
Why?
|
| Female | 7 | 2024 | 149107 | 0.050 |
Why?
|
| Internet | 2 | 2018 | 691 | 0.050 |
Why?
|
| Immunomodulation | 1 | 2024 | 255 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2023 | 133 | 0.050 |
Why?
|
| ras Proteins | 3 | 2011 | 804 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2023 | 339 | 0.050 |
Why?
|
| beta-Glucans | 2 | 2012 | 35 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 369 | 0.050 |
Why?
|
| Software | 2 | 2018 | 1356 | 0.050 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2022 | 288 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2022 | 214 | 0.040 |
Why?
|
| Antigens, CD1d | 1 | 2020 | 26 | 0.040 |
Why?
|
| NEDD8 Protein | 1 | 2020 | 23 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2020 | 122 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 2011 | 378 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 440 | 0.040 |
Why?
|
| Adenylyl Cyclases | 2 | 2010 | 103 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 224 | 0.040 |
Why?
|
| Genes, Switch | 2 | 2010 | 16 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 162 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 354 | 0.040 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2019 | 78 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2021 | 247 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 1076 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 654 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2021 | 9294 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 230 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 7104 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 757 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2018 | 45 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 151 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 16216 | 0.040 |
Why?
|
| Microsatellite Instability | 1 | 2020 | 409 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 1121 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2015 | 1564 | 0.040 |
Why?
|
| Epitopes | 1 | 2020 | 707 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 965 | 0.040 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 1 | 2017 | 6 | 0.040 |
Why?
|
| Protein Domains | 1 | 2018 | 323 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 329 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 739 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 16689 | 0.030 |
Why?
|
| Mitosis | 1 | 2019 | 681 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2024 | 1253 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2017 | 136 | 0.030 |
Why?
|
| Models, Biological | 2 | 2020 | 3198 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2017 | 163 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 223 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 338 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 1432 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 2455 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 1827 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 288 | 0.030 |
Why?
|
| Gene Library | 1 | 2016 | 353 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 314 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2014 | 101 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 1274 | 0.030 |
Why?
|
| Prenylation | 1 | 2014 | 5 | 0.030 |
Why?
|
| Proteostasis Deficiencies | 1 | 2014 | 6 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 722 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2014 | 80 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2022 | 2376 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 503 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 3531 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1097 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 2034 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 492 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 1655 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2012 | 14 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 588 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 2137 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 4224 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2019 | 4329 | 0.020 |
Why?
|
| Binding Sites | 1 | 2016 | 2256 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 2011 | 94 | 0.020 |
Why?
|
| Permeability | 1 | 2011 | 160 | 0.020 |
Why?
|
| Brain | 1 | 2024 | 4213 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1742 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1958 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3846 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2011 | 128 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1570 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 5731 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 269 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2017 | 696 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 809 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3035 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 501 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2020 | 3078 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 240 | 0.020 |
Why?
|
| Carbonic Anhydrases | 1 | 2009 | 50 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 7665 | 0.020 |
Why?
|
| Apoptosis | 1 | 2023 | 7758 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 538 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 5698 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 1471 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 6526 | 0.020 |
Why?
|
| Virulence | 1 | 2008 | 352 | 0.020 |
Why?
|
| Copper | 1 | 2008 | 165 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7389 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 324 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 877 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 1474 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 5071 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 7896 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6195 | 0.020 |
Why?
|
| Spleen | 1 | 2008 | 726 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 909 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 13024 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2011 | 880 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 2518 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 3707 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 4645 | 0.010 |
Why?
|
| Child | 1 | 2022 | 30578 | 0.010 |
Why?
|
| Kidney | 1 | 2008 | 2122 | 0.010 |
Why?
|
| Liver | 1 | 2008 | 3088 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 5063 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 14623 | 0.010 |
Why?
|
| Male | 1 | 2018 | 128533 | 0.000 |
Why?
|